|
Dr. Victor Forys, Press Conference
We need to stop dividing patients into women, men, breast cancer patients, prostate cancer patients, asthma patients, hypertension patients, diabetes patients, and unite ALL PATIENTS to pass real health insurance coverage for people over age 49 that get any illness or cancer, even if they lose their job. That is the real issue" said Dr. Victor Forys. "We are all patients," said Dr. Victor Forys. "The biggest threat to the health of millions of Americans isn't cancer, diabetes, heart disease, or high blood pressure, it's the lack of health care coverage and we can cure that right now," Dr. Victor Forys "That's the biggest threat to the health of Americans - one in six, 47 million Americans lack insurance," said Dr. Forys. Contrary to Sara's new slick television ad, the battle is not over.
Take Herbal Supplements to Retain Youth
Green may be beneficial in reducing the risk of breast cancer, prostate cancer, colon cancer and gastric cancer. They are also beneficial to maintain remission in persons with Crohn's disease, to prevent Parkinson's disease and help protect against heart disease, dental caries and kidney stones.
• Guggulipid Extract Supplements: These supplements are used for arthritis, lowering high cholesterol, atherosclerosis, nodulocystic acne, skin diseases and weight loss.
• Olive Leaf Extract Supplements: These supplements are used for fungus and yeast infections, frequent colds, asthma, vaginal yeast infections, rheumatoid arthritis, diabetes, bacterial infections, herpes, AIDS, chronic fatigue, flu and colds.
• Tumeric Extract Supplements: These supplements are beneficial for preventing rheumatoid arthritis, cancer, atherosclerosis, bursitis, genital herpes, hepatitis, HIV support, low back pain and osteoarthritis.
Engineers create 'intelligent' molecules
Smolke's team focuses on well-researched model systems in breast, prostate and brain cancers, including immunotherapy applications based on reprogramming human immune response to different diseases. The researchers work directly with clinicians at the City of Hope Cancer Center (a National Cancer Institute designated Comprehensive Cancer Center in Duarte, Calif.) who have ongoing immunotherapy trials for treating glioma, a severe type of brain cancer. "Our goal is to make more effective therapies by taking advantage of the natural capabilities of our immune system and introducing slight modifications in cases where it is not doing what we would like it to do," Smolke said. She hopes to translate her technologies into intelligent cellular therapeutics for glioma patients in the next five years.
Volunteers needed for multicultural street festival in Clearwater
Clinical alternative pharmacist Pamela Seefeld will discuss alternative ways to prevent cancer and disease, treat mental health, and prevent hereditary illnesses. She also will discuss how to use vitamins and supplements to boost energy and lose weight. For information, call (727) 562-4970. Dunedin Volunteer to look out for pedestrians Dunedin is accepting applications to fill a vacancy on the Metropolitan Planning Organization's Pedestrian Transportation Advisory Committee. The individual will assist the MPO with pedestrian planning, plan review, plan implementation, education and coordination and pedestrian safety. Meetings are held the third Monday of each month. For information and an application, visit www.dunedingov.com or call (727) 298-3035.
European Commisssion Grants Ferring Pharmaceuticals Approval of
(ii) Testosterone plays a major role in the growth and spread of prostate cancer cells. The data show that degarelix provided an extremely fast effect on testosterone levels, close to the immediate effect achieved with surgery (orchidectomy).(ii,iii) "We are delighted with the approval of FIRMAGON(R) (degarelix), which demonstrated in clinical trials both an immediate onset of action and a profound long-term suppression of testosterone and PSA" commented Dr. Pascal Danglas, Executive Vice President Clinical & Product Development at Ferring Pharmaceuticals. "We will work with local authorities to ensure the launch of FIRMAGON to patients across European Union countries as soon as possible." The European Commission approval for FIRMAGON(R) (degarelix) follows approval from the FDA in the US in December 2008.
'I Practise What I Preach ..i Had To Get Involved'
The Beatson Translational Research Centre is set to become the first laboratory in Scotland dedicated to turning scientific discoveries into cancer treatments. It is Kirsty's job to manage the staff who organise the events programme. She also recruits and trains volunteers who offer their assistance to the appeal. The £1K Challenge was launched recently by television presenter Shereen Nanjiani. Farmer's wife Kirsty, who is based at Glasgow University, has signed up to give a regular gift under the appeal, which lets her see her donations build up from month to month like a mound of pebbles. She said: "We are on the lookout for people to get involved in the campaign, whether it's taking part in the £1K Challenge or at one of our appeal events." The Beatson Translational Research Centre will be built at Garscube Estate in Bearsden, Glasgow, and will focus on a range of cancers that are common in Scotland such as breast, prostate, ovarian, lung, throat, mouth, stomach and gastro intestinal.
Fight in these dogs
He beat prostate cancer in 2003 and skin cancer two years ago. But last summer, when doctors removed 36 lymph nodes they feared were cancerous, Calhoun was a bit more rattled than before. He lost 24 pounds during his six weeks of radiation treatment, which caused fatigue and the dulling of some of his taste buds. Folks around the Connecticut basketball program thought Calhoun had coached his last game. Calhoun, though, said he never gave it a thought. "Why would I do that?" he asked reporters. "Why quit doing something you love?" Especially when you do it so well? Four other teams held the No. 1 spot in the Associated Press poll before Connecticut catapulted to the top on Monday. Unlike their predecessors, the Huskies – who are 21-1 overall and 10-1 in the Big East – don't appear ready to relinquish their status anytime soon.
Tweeters as editors, sources, merchants?
Politics winner @justin_hart promoted a politician while Scott Zagarino @athletes4acure spoke out about prostate cancer when accepting the nonprofits prize. Martin Sargent @martinsargent, won the weird category and took a dig at the platform itself. "What's truly weird is that by receiving the $1,000 grant that accompanies this award, I'm 1,000 times more profitable than Twitter. Thank you." Another contendor for the weird prize, @Matman showed up at the party in an outfit to promote WellComeMat.com Then there was the mix of attendees, many of whom paid a $60 entrance fee, besides the reporters who gave the event pretty wide coverage. Nora Abousteit, who runs an open source sewing pattern web site burdaStyle.com, said she depends so much on Twitter for media updates that she changed her cellphone number and service after discovering twitter didn't work well on her old phone.
Video: The MDS Foundation Says Published Data Confirms VIDAZA(R
VIDAZA turns these genes back on through a system of actions called epigenetics, a new approach to cancer treatment. It is also the first drug to achieve transfusion independence in more than 40% of patients. Transfusions can be time consuming, debilitating and run the risk of iron overload that can be fatal. MDS patient Bob Urbanski notes, "I needed blood transfusions as often as twice a month, but with VIDAZA I haven't needed a transfusion for at least 14 weeks." The published data refer specifically to categories of MDS known as intermediate-2 or high-risk MDS, as well as AML with 20 to 30 percent bone marrow blasts. VIDAZA has been available in the United States for four years and it was recently approved in Europe. About MDS MDS is a primary neoplasm of the bone marrow that is more prevalent than any of the leukemias.
Vitamin D deficiency may increase risk of colds, flu
"A respiratory infection in someone with otherwise healthy lungs usually causes a few days of relatively mild symptoms," explains Carlos Camargo, MD, DrPH, MGH Department of Emergency Medicine and senior author of the study. "But respiratory infections in individuals with an underlying lung disease can cause serious attacks of asthma or COPD that may require urgent office visits, emergency department visits or hospitalizations. So the impact of preventing infections in these patients could be very large."
The authors stress that the study's results need to be confirmed in clinical trials before vitamin D can be recommended to prevent colds and flu. "We are planning clinical trials to test the effectiveness of vitamin D to boost immunity and fight respiratory infection, with a focus on individuals with asthma and COPD, as well as children and older adults � groups that are at higher risk for more severe illness," Ginde says.
|
